Kobe, Japan

Takahiro Mukai

This inventor holds 1 USPTO granted patent. Top assignees: Hamamatsu University School of Medicine, Kyushu University, Nagasaki University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahiro Mukai. Retrieved from https://idiyas.com/inventor/takahiro-mukai-a4yiw726

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takahiro Mukai: Innovator in Antigen and Drug Delivery Systems

Introduction

Takahiro Mukai is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent that focuses on antigen and drug delivery complexes. His work aims to enhance the effectiveness of delivering various antigens and drugs to specific cells or organs.

Latest Patents

Mukai holds a patent for a "Composite body for antigen or drug delivery." This invention provides a complex that includes an antigen or drug combined with a cationic molecule, encapsulated by an anionic molecule. This delivery complex serves as a crucial component in drug delivery systems, facilitating targeted delivery to particular cells or organs.

Career Highlights

Throughout his career, Takahiro Mukai has been associated with prestigious institutions such as Nagasaki University and Kyushu University Corporation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Mukai has collaborated with notable colleagues, including Hitoshi Sasaki and Tomoaki Kurosaki. These partnerships have further enriched his research and development efforts in the field of drug delivery.

Conclusion

Takahiro Mukai's innovative work in antigen and drug delivery systems showcases his commitment to advancing medical science. His contributions are vital for the development of more effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…